Document Type
|
:
|
BL
|
Record Number
|
:
|
634518
|
Doc. No
|
:
|
dltt
|
Main Entry
|
:
|
Moore, Elaine A.,1948-
|
Title & Author
|
:
|
The amphetamine debate : : the use of Adderall, Ritalin, and related drugs for behavior modification, neuroenhancement and anti-aging purposes /\ Elaine A. Moore ; foreword by K. Scott Pacer
|
Publication Statement
|
:
|
Jefferson, N.C. :: McFarland & Co.,, c2011
|
Series Statement
|
:
|
McFarland health topics ;; [10]
|
Page. NO
|
:
|
viii, 240 p. :: ill. ;; 23 cm
|
ISBN
|
:
|
9780786458738 (softcover : alk. paper)
|
|
:
|
: 0786458739 (softcover : alk. paper)
|
Bibliographies/Indexes
|
:
|
Includes bibliographical references and index
|
Contents
|
:
|
History of amphetamine and related psychostimulants -- Medical and other effects of amphetamine compounds -- Attention deficit hyperactivity disorder (ADHD) -- Ritalin, Adderall, and other treatments for ADHD -- Amphetamines as cognitive and performance enhancers -- Methamphetamine-from pervitin to desoxyn to crystal meth -- Amphetamines and drug dependence -- Short and long term adverse effects of psychostimulants -- The neuroscience revolution : what comes next?
|
Abstract
|
:
|
"This book covers both sides of Adderall prescription and use. It discusses the history of amphetamine and related stimulants; ADHD and the use of Ritalin and Adderall to treat it; related neuroenhancers; methamphetamine from Desoxyn to crystal meth; the nature of addiction and side effects; sociological effects of amphetamine compounds; and expert opinions for and against Adderall use"--Provided by publisher
|
Subject
|
:
|
Amphetamines
|
Subject
|
:
|
Methylphenidate
|
Subject
|
:
|
Central nervous system stimulants
|
Subject
|
:
|
Attention-deficit hyperactivity disorder-- Chemotherapy
|
Subject
|
:
|
Amphetamines-- therapeutic use
|
Subject
|
:
|
Amphetamine-Related Disorders-- psychology
|
Subject
|
:
|
Amphetamines-- adverse effects
|
Subject
|
:
|
Attention Deficit Disorder with Hyperactivity-- drug therapy
|
Subject
|
:
|
Methylphenidate-- therapeutic use
|
Dewey Classification
|
:
|
362.29/9
|
LC Classification
|
:
|
RC568.A45M66 2011
|
NLM classification
|
:
|
2010 N-017
|
|
:
|
QV 102
|